Last reviewed · How we verify

NCT03098264

Safety and Efficacy of Simultaneous or Staged Surgery on Complicated Hepatolithiasis

Status unknown NA Last updated 12 April 2017
What this trial tests

NA trial testing Simultaneous surgery in Hepatolithiasis in 92 participants. Status unknown.

Timeline
11 April 2017
Primary endpoint
30 December 2018
31 December 2018

Quick facts

Lead sponsorSouthwest Hospital, China
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment92
Start date11 April 2017
Primary completion30 December 2018
Estimated completion31 December 2018
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Southwest Hospital, China

Who can join

Adults 18 to 65, any sex, with Hepatolithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For some complicated hepatolithiasis, it is difficult to decide whether to perform surgery on biliary stone and portal hypertension simultaneously or separately by staged surgery.There's a high risk of intraoperative bleeding, postoperative liver failure and variceal bleeding for these patients.How to develop a optimized algorism of simultaneous and staged surgery is highly needed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Simultaneous surgery

Trials testing the same drug.

Other Southwest Hospital, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03098264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing